MannKind Corp (MNKD) Stock Analysis

MannKind Corp (MNKD) is a publicly traded company in the HEALTHCARE sector. It trades at $3.43, carries a market capitalization of $1.09B. This page summarizes the public market data, fundamentals, and frequently asked questions for MNKD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.43
• Market Cap: $1.09B
• EPS: $-0.07
• 52-Week High: $6.51
• 52-Week Low: $2.23

Market Sentiment

MannKind Corp currently has a Bullish sentiment score of 0.46.

About MannKind Corp

MannKind Corporation is a biopharmaceutical innovator based in Westlake Village, California, specializing in inhaled therapeutics for endocrine disorders and orphan lung diseases. Utilizing its proprietary Technosphere® platform, the company markets Afrezza, an inhaled insulin designed to enhance glycemic control for diabetes patients, thereby addressing critical unmet medical needs. Committed to pioneering advanced pulmonary delivery systems, MannKind is positioned to significantly improve t...

GNG Research Analysis

GNG Research scores MannKind Corp (MNKD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MNKD.

Frequently Asked Questions

Does MNKD pay dividends?

MannKind Corp (MNKD) does not currently pay a regular dividend.

What is MNKD's market cap?

MannKind Corp (MNKD) has a market capitalization of $1.09B with a current stock price of $3.43.